Erythropoiesis-stimulating agents for the treatment of myelodysplastic syndrome-related anemia

被引：0
|
作者：
Gascon, P. [1 ]
Krendyukov, A. [2 ]
Mathieson, N. [2 ]
Aapro, M. [3 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Hematol Oncol, Barcelona, Spain
[2] HEXAL AG, Sandoz Biopharmaceut, Holzkirchen, Germany
[3] Clin Genolier, Canc Ctr, Genolier, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P730
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease
    Nicolas Roberto Robles
    Clinical Drug Investigation, 2016, 36 : 421 - 431
  • [42] Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia
    Inzoli, Elena
    Crisa, Elena
    Pugliese, Novella
    Civettini, Ivan
    Lanzarone, Giuseppe
    Castelli, Andrea
    Martinelli, Vincenzo
    Montelisciani, Laura
    Antolini, Laura
    Gambacorti-Passerini, Carlo
    Elli, Elena Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (04) : 354 - 361
  • [43] Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?
    Venturino, A.
    Colloca, G.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 905 - 906
  • [44] Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia
    Lappin, Terence R.
    Maxwell, A. Peter
    Johnston, Patrick G.
    ONCOLOGIST, 2007, 12 (04): : 362 - 365
  • [45] Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents
    Joerg, David J.
    Fuertinger, Doris H.
    Kotanko, Peter
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (01)
  • [46] Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes
    Gowanlock, Zachary
    Sriram, Swetha
    Martin, Alison
    Xenocostas, Anargyros
    Lazo-Langner, Alejandro
    BLOOD ADVANCES, 2017, 1 (19) : 1538 - 1545
  • [47] Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents
    Geisler, Benjamin P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (08) : 1209 - 1216
  • [48] ERYTHROPOIESIS-STIMULATING AGENTS IN RENAL ANEMIA: WHAT WE LEARNED IN TAIWAN
    Der-Cherng, Tarng
    NEPHROLOGY, 2014, 19 : 21 - 21
  • [49] Correcting Anemia in Heart Failure: The Efficacy and Safety of Erythropoiesis-Stimulating Agents
    Lawler, Patrick R.
    Filion, Kristian B.
    Eisenberg, Mark J.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : 649 - 658
  • [50] Anemia management with erythropoiesis-stimulating agents: A risk-benefit update
    Aapro, Matti S.
    ONCOLOGIST, 2008, 13 : 1 - 3
12345